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Hypercholesterolemia is a prerequisite for puromycin induc- Loss of glomerular filtration barrier function is mani-
ible damage in mouse kidney. fested by a clinical sign, proteinuria. Increasing evidence
Background. The mouse, as opposed to the rat, is relatively shows that the slit diaphragms between interconnectingresistant to the experimental nephrosis induced by puromycin
foot processes of glomerular epithelial cells, podocytes,aminonucleoside. The reason for this species specificity is not
are directly involved in the maintenance of an effectiveknown. Apolipoprotein E (apoE)-deficient mice were used to
determine whether hypercholesterolemia plays a role in induc- filtration barrier. Kestila¨ et al recently identified the gene
ing proteinuria. NPHS1 mutated in congenital nephrotic syndrome of the
Methods. Thirty-two mice were divided into normal and high Finnish type (CNF) patients [1]. The NPHS1 gene encodes
cholesterol diet groups and then divided further into four sub-
a transmembrane protein of podocytes, nephrin, whichgroups: puromycin, puromycinprobucol, probucol and control.
is a major component of the slit diaphragms [2, 3] andUrinary albumin of these mice was analyzed by nephelometry.
The lipid peroxidation (LPO) end products malonyldialdehyde an important regulator of glomerular permeability [4, 5].
(MDA) and 4-hydroxynonenal (4-HNE) were detected by im- Previous results have shown that in the Heymann ne-
munohistochemistry, and the expression level of the glomerular phritis model of immune complex glomerulonephritis,
slit diaphragm protein, nephrin, was studied by immunohisto- proteinuria is associated with enhanced local lipid peroxi-chemistry and real time RT-PCR.
dation (LPO) [6, 7] particularly in the podocytes. Addi-Results. Overt proteinuria was induced by puromycin only
tional evidence of LPO involvement derives from studiesin the apoE knockout mice ingesting the high cholesterol diet.
The staining intensities of MDA and 4-HNE were stronger in with the lipid antioxidant probucol showing decrease in
the glomeruli of proteinuric mice compared to glomeruli of non- proteinuria, morphological damage and LPO end prod-
proteinuric mice. When serum cholesterol levels were reduced ucts [6, 7]. The effect of probucol also has been estab-by probucol, proteinuria decreased and fewer LPO end prod-
lished in the puromycin aminonucleoside nephrosis (PAN)ucts were seen immunohistochemically. Three and eight days
model of the rat [8, 9]. Interestingly, while puromycinafter puromycin injection the level of nephrin mRNA in the
kidneys of proteinuric mice decreased in comparison to the readily induces a massively proteinuric disease in the rat
controls. Puromycin-treated mice kidneys demonstrated a clearly that closely mimics human minimal change disease both
reduced reactivity to the nephrin antibodies. morphologically and functionally, the mouse has been
Conclusions. Hypercholesterolemia, possibly via LPO, is a
resistant to similar effects of puromycin. On the otherprerequisite for puromycin-inducible glomerular damage in the
hand, proteinuria has been successfully induced in micemouse. Furthermore, nephrin protein and mRNA levels appear
to be candidate markers of glomerular damage in the mouse. with adriamycin by a probable mechanism of immune-
system–mediated toxic effect [10, 11].
Lipid abnormalities, including hyperlipidemia and dysli-
poproteinemia, are consistent findings in patients with
renal diseases [12, 13]. We tested the hypothesis that high
serum cholesterol is a prerequisite for damage to the1 Drs. Cheng and Pa¨ta¨ri contributed equally to this study.
filtration barrier in animals resistant to puromycin induc-
Key words: proteinuria, lipid peroxidation, apolipoprotein E, nephrin, ible proteinuria, for example, mice. For this purpose we
puromycin, glomerular damage. used apolipoprotein E (apoE) knockout mice with high
cholesterol levels to induce the PAN model. Albumin-Received for publication June 27, 2001
uria, nephrin protein and mRNA levels as well as LPOand in revised form April 17, 2002
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METHODS purified rabbit polyclonal antibody (1:100 dilution in
PBS) against the intracellular domain of nephrin wasExperimental animals
used as the primary antibody [18]. The secondary anti-
The ApoE knockout mouse line originally was de- body was FITC conjugated rat anti-rabbit IgG (Dako).
scribed by Plump et al [14]. Thirty-two mice were To semiquantitate the nephrin protein expression in kid-
randomly assigned to two main dietary groups: apoE ney tissue in apoE group-2 kidney tissues, a dilution
group-1 comprised eight mice fed with normal mouse series of the first antibody (1:30; 1:60; 1:120; 1:240; 1:480;
chow diet, and apoE group-2 contained 24 mice fed with 1:960 in PBS) was applied to the sections, and the end
a high fat diet [21% (wt/wt) fat, 0.15% (wt/wt) choles- point of specific fluorescence was recorded by two inde-
terol, 19.5% (wt/wt) casein, no sodium cholate; Harlan pendent observers. The staining intensities of the dilu-
Teklad TD 88137, Zeist, The Netherlands). The mice tion series sections were scaled as negative (), faintly
were further divided into four treatment subgroups: con- positive (), positive (), and strong positive (),
trol, puromycin, probucol prior to puromycin, and pro- and the sections from the mice groups were compared
bucol alone. The PAN model was induced by a single to them to assess the level of nephrin protein expression.
intraperitoneal injection of puromycin aminonucleoside An average of 15 glomeruli from each mouse were ob-
(15 mg/100 g; Sigma Chemical Co., St. Louis, MO, USA) served. Immunofluorescence was examined by using an
and the control subgroups received equal volume of Olympus OX50 microscope equipped with an epi-illumi-
0.9% saline similarly. The probucol subgroups received nator and a filter system for FITC fluorescence.
probucol (Sigma Chemicals) treatment for 10 days be-
fore the puromycin or saline injection. Probucol was RNA isolation
given in the diet (2% wt/wt) mixed in the pellets, and The total RNA was isolated from the frozen cortical
the consumption was recorded daily. The urine samples kidney tissues (10 to 88 mg) of the mice using the acid
were collected using metabolic cages at days 0, 3 and 8 guanidium thiocyanate-phenol-chloroform single-step pro-
in the apoE group-2 and at days 0 and 8 in the apoE cedure with Trizol reagent (Life Technologies; Gibco
group-1 after the puromycin or saline injection. The BRL, Paisley, UK) according to the manufacturer’s in-
apoE group-1 mice were killed at day 8, and the blood structions [19, 20]. Then, the isolated RNA was incu-
samples and cortical kidney slices were taken, frozen to bated with DNase I (Promega, Madison, WI, USA) and
80C in liquid nitrogen and stored frozen until analyses. human placental RNase inhibitor (Promega) for 30 min-
From apoE group-2, three mice from each subgroup (12 utes at 37C to remove genomic DNA [16].
total) were killed at day 3, and the rest of the mice were
killed at day 8. The blood samples and the cortical kidney Real-time reverse transcription-polymerase chain
reaction (RT-PCR)slices were stored in 80C.
The obtained RNA samples were transcribed into
Analysis of urinary albumin and serum lipids cDNA using oligo dT15 priming (Roche Diagnostics
The urinary albumin concentration was measured by GmbH, Mannheim, Germany) and Moloney-Murine Leu-
nephelometry [4], whereas the serum cholesterol and kemia Virus reverse transcriptase (Promega) according
triglyceride concentrations were measured enzymatically to the standard procedure [4]. The nephrin expression
[15]. Analysis of variance (ANOVA) was used for the was quantitated with a real time quantitative PCR detec-
statistics. tion method. All PCR reactions were performed using
Taqman Real-Time PCR ABI Prism 7700 Sequence
Immunohistochemistry Detector System (Perkin-Elmer Applied Biosystems,
Kidney cortices of mice from the apoE group-2 that Norwalk, CT, USA) in a Taqman Universal Master Mix.
were killed at days 3 and 8 after puromycin injection were A FAM (6-carboxy-fluorescein) labeled probe 5-ccctct
used for the immunohistochemical analyses as described ctaaatgcacggccacca-3 and a primer pair 5-atctccaagacc
earlier [16, 17]. Briefly, cryostat sections (4 m) were pre- ccaggtacaca-3 (forward) and 5-agggtcagggcgctgat-3 (re-
pared and fixed for five minutes in acetone at20C. Then, verse) were used for amplification of mouse nephrin. The
the sections were incubated with rabbit antisera to malon- experiments were performed as triplicates for each data
dialdehyde (MDA) and 4-hydroxynonenal (4-HNE; gen- point. The standard curve method was used in the calcu-
erously supplied by T. Montine, University of Texas, Hous- lation of the results and the expression of glyceraldehyde
ton, TX, USA) (1:50 dilution in phosphate-buffered saline phosphate dehydrogenase (GAPDH), a housekeeping
[PBS]) overnight at 4C. The sections were incubated gene, was used to normalize the expression results of
with fluorescein isothiocyanate (FITC) conjugated rat anti nephrin. To construct a standard curve, the relative ki-
rabbit IgG (Dako, Glostrup, Denmark; 1:100 in PBS netic method was applied and the curve was constructed
containing 5% normal rat serum) for half an hour at room with twofold serial dilutions of total cDNA from the
kidney tissue of control mice with six points of dilutiontemperature. For immunostaining of nephrin, an affinity-
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Table 1. Serum lipid levels of apoE knockout mice at
postinduction day 8
apoE group-1 apoE group-2
Group Chol Trigly Chol Trigly
P 10.43.0 1.50.7 53.710.1a 4.10.3
PPro 8.451.2 3.90.4 24.76.4a 9.14.0
Pro 6.05.5 2.40.4 22.02.2a 21.27.1b
Control 11.62.4 1.70.3 81.22.9 7.40.1
Data are mmol/L  SD. Abbreviations are: P, puromycin; Pro, probucol;
Chol, cholesterol; Trigly, triglyceride.
a P  0.01, b P  0.05
Fig. 1. Urinary albumin concentrations in the apoE group-2 mice (high
(1, 0.5, 0.25, 0.125, 0.0625, 0.03125). The primer pairs cholesterol diet), 3 and 8 days after the puromycin injection. Symbols
are: () control; ( ) puromycin; ( ) puromycin probucol; ( ) probu-of rodent GAPDH were purchased from Perkin-Elmer.
col. Data are presented as means  SD. *P  0.01.Finally, the nephrin mRNA level of each mouse was
compared to its GAPDH mRNA level. The results of
apoE group-2 mice were shown as mean with SD and
ANOVA was used for statistics.
RESULTS
Lipid abnormalities and proteinuria
With the normal mouse diet, the apoE knockout mice
(apoE group-1) subgroups had no difference in serum
cholesterol and triglyceride levels compared to the con-
trol subgroup at puromycin postinduction day 8, as indi-
cated in Table 1. With a high fat diet (apoE group-2), the
serum cholesterol and triglyceride levels of the control Fig. 2. Immunohistochemistry for malonyldialdehyde (MDA) in the
puromycin treated (a) and control (b) mouse glomeruli of the apoEsubgroup increased sevenfold and fourfold, respectively,
group-2 (high cholesterol diet). Note the prominent mesangial reactivityin comparison to the levels of the controls ingesting a in panel a.
normal diet. These data are consistent with previously
described results [14]. In the puromycin subgroup ingest-
ing a high fat diet, there was a 34% decrease in the serum
Lipid peroxidationcholesterol level compared to the control subgroup. The
reason for this is unclear, as no cholesterol was found The localization of lipid peroxidation end products
in the urine of the mice at day 8 by the enzymatic method was studied in kidney cortex tissues taken from the apoE
(data not shown) [15]. Probucol reduced the cholesterol group-2 mice at day 3 after puromycin injection. The
level alone or when used with puromycin by 70%, but glomerular accumulation of MDA in the apoE group-2
a reciprocal increase was observed in the triglyceride mice subjected to puromycin was more intense compared
level when probucol was used alone. to the control group and appeared to localize more to
Urinary albumin levels of the apoE group-2 mice were the mesangial aspect, while remarkable granular staining
measured at days 3 and 8 after puromycin injection. At of podocytes, as defined by their localization adjacent
day 3 the puromycin treated mice were approximately to the urinary space, was seen (Fig. 2a). In the control
sixfold more proteinuric compared to their controls, mice as well as in the mice treated with probucol prior
whereas the levels returned to normal at day 8 (Fig. 1). to puromycin, only faint MDA reactivity was observed
The urinary albumin of the mice treated with probucol (Fig. 2b). A closely similar reactivity pattern was ob-
prior to puromycin showed approximately a threefold served in the samples stained for 4-HNE (data not
increase, so probucol decreased the degree of proteinuria shown). In control stainings without primary antibodies
caused by puromycin by 50%, even though the change only negligible reactivity was seen.
was not statistically significant (P  0.05). The urinary
Expression of nephrinalbumin levels of the apoE group-1 mice were analyzed
as well, but no significant changes were found compared The level of nephrin-specific mRNA in the kidney
to the levels of the control subgroup of apoE group-2 cortex of apoE group-2 mice decreased 30% and 50%
at days 3 and 8 after puromycin injection, respectively,(data not shown).
Cheng et al: Puromycin damage in mouse kidney110
Fig. 4. Immunofluorescence staining of mouse glomeruli from apoE
group-2 (high cholesterol diet) with anti-nephrin antibody. The control tis-
sue (a) shows a strong epithelial staining pattern in the glomerulus, while
only very weak reactivity is seen in the puromycin treated kidney (b).
Fig. 3. Amount of nephrin-specific mRNA in the apoE group-2 (high
cholesterol diet) as determined by real time reverse transcription-poly-
merase chain reaction (RT-PCR) and normalized with the respective Table 2. Nephrin protein expression in kidney tissues of
GAPDH mRNA. Symbols are: () control; ( ) puromycin; ( ) apoE group-2 mice shown by intensity of immunofluorescence
puromycin  probucol; ( ) probucol. The mean of each subgroup  staining compared to the dilution series
SD is shown.
Dilution of
primary antibody P PPro Control
1:30   
1:60   compared to the control subgroup, although the changes
1:120   were not statistically significant (Fig. 3). In contrast, 1:240   
treatment with probucol prior to puromycin or alone 1:480   
1:960   increased the nephrin mRNA level to some extent com-
Staining scale: negative (), faint positive (), positive () and strongpared to the control at days 3 and 8. The increasing ef-
positive (). Abbreviations are: P, puromycin; Pro, probucol.fect of probucol on nephrin mRNA is consistent with
previous data [4]. Antibodies against the intracellular
domain of nephrin showed a typical strong granular epi-
thelial staining pattern in the glomeruli of the controls injection yields massive proteinuria in the rat [21, 22],
(Fig. 4a) and of the subgroups treated with probucol little or no proteinuria has been observed in mice with
the same protocols. The reason for this action has re-together with puromycin, or probucol alone. Using the
mained unknown. In some experimental mouse models,same dilutions in the kidneys of puromycin-treated mice
however, the animals have become proteinuric after re-a clearly reduced reactivity was observed (Fig. 4b). The
peated injections [23], suggesting that distinct differencessemiquantitation of nephrin protein expression in tissues
in the susceptibility exist, such as in the PAN model usingby end-point titration further verified the decrease in
the hyperprolinemic PRO/Re mouse strain [24]. In thesestaining intensity as shown in Table 2. A non-specific
models, as investigated with scanning electron micros-antibody or secondary antibody alone failed to show
copy the morphological changes in the affected glomerulireactivity.
resemble the changes observed in the rat models. Thus,
the induction of proteinuria by PAN as demonstrated
DISCUSSION in our current study most probably also represents glo-
This study establishes a murine model of the PAN merular proteinuria. The current results show that an
model using genetically modified mice with an inacti- elevated serum cholesterol level is a prerequisite for
vated apolipoprotein E gene. Only ApoE-deficient mice the damage to the glomerular filtration barrier. This is
on high fat diet with vastly elevated serum cholesterol indirectly supported by the fact that high cholesterol is
levels were prone to proteinuria. The use of the lipid a frequent finding in the human glomerular diseases [12,
antioxidant probucol prior to puromycin treatment re- 13, 25]. Thus, it may be causally, rather than secondarily,
duced the level of serum cholesterol and also proteinuria involved with glomerular damage in humans as well.
to some extent. Therefore, we suggest that there is a LPO appears to be directly associated with glomerular
possible role for cholesterol and, particularly, local lipid damage. Kerjaschki et al observed an increase in LPO
peroxidation in the induction of PAN and proteinuria end products in Heymann nephritis model of membranous
in general. glomerulonephritis [7, 26], and showed that type IV colla-
Induction of proteinuria with puromycin in mice has gen is the major target for lipoperoxide damage in this
model. Furthermore, Gwinner et al demonstrated thatproven to be problematic. While a single intraperitoneal
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LPO is associated with the glomerular functional damage [1]. Homozygous nephrin deficiency in the knockout
mouse similarly leads to massive proteinuria, early peri-in the PAN model of the rat [8]. Puromycin may induce
a remarkable mitochondrial damage [27], which conse- natal lethality and loss of interpodocyte slit diaphragms
quently leads to a fall in the cellular adenosine 5-triphos- [40, 41]. Furthermore, nephrin is involved in experimen-
phate (ATP) levels, further loss of mitochondrial func- tal and human proteinuric diseases [4, 5, 42, 43] as well
tion, and an avalanche of tissue-damaging LPO. Earlier, as in primary acquired nephrotic syndrome [44]. Interest-
Diamond, Bonventre and Karnovsky showed the forma- ingly, in our present study there was a tendency for the
tion of reactive oxygen species via the enhanced xanthine animals to show a down-regulation of nephrin mRNA
pathway in PAN [28]. Hypoxanthine, a breakdown prod- with puromycin as well as increase of nephrin mRNA
uct of puromycin, appears to lead directly to the forma- after the probucol, which suggests that nephrin is also a
tion of free oxygen radicals [29, 30]. Furthermore, adeno- candidate indicator molecule of the functional glomeru-
sine deaminase (ADA) is involved in this pathway by lar filtration barrier in the mouse.
regulating the formation of reactive oxygen species [31].
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